Ashraf Virmani

2.4k total citations · 1 hit paper
65 papers, 1.8k citations indexed

About

Ashraf Virmani is a scholar working on Molecular Biology, Clinical Biochemistry and Reproductive Medicine. According to data from OpenAlex, Ashraf Virmani has authored 65 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 28 papers in Clinical Biochemistry and 16 papers in Reproductive Medicine. Recurrent topics in Ashraf Virmani's work include Metabolism and Genetic Disorders (28 papers), Mitochondrial Function and Pathology (15 papers) and Neuroscience and Neuropharmacology Research (12 papers). Ashraf Virmani is often cited by papers focused on Metabolism and Genetic Disorders (28 papers), Mitochondrial Function and Pathology (15 papers) and Neuroscience and Neuropharmacology Research (12 papers). Ashraf Virmani collaborates with scholars based in Italy, United States and Switzerland. Ashraf Virmani's co-authors include Zbigniew Binienda, Syed F. Ali, Stanko S. Stojilković, Kevin Catt, Sylvie Dufour, Lazar Z. Krsmanović, F Merelli, Syed Imam, Stefania Rossi and Gian Maria Busetto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Ashraf Virmani

62 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Role of l-Carnitine in Mitochondria, Prevention of Metabolic Inflexibility and Disease Initiation

2022 143 citations Ashraf Virmani et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ashraf Virmani Italy	23	738	404	394	367	294	65	1.8k
Giuseppina Di Stefano Italy	27	522 0.7×	90 0.2×	106 0.3×	564 1.5×	263 0.9×	91	2.2k
Aleardo Koverech Italy	16	374 0.5×	147 0.4×	168 0.4×	207 0.6×	54 0.2×	19	1.1k
Zbigniew Binienda United States	26	777 1.1×	39 0.1×	275 0.7×	305 0.8×	492 1.7×	72	1.9k
Christian‐Alexandre Castellano Canada	27	667 0.9×	102 0.3×	343 0.9×	1.8k 4.9×	120 0.4×	55	2.6k
Li Ma China	28	1.0k 1.4×	38 0.1×	159 0.4×	287 0.8×	364 1.2×	129	2.6k
Pedro Montilla Spain	29	475 0.6×	42 0.1×	101 0.3×	463 1.3×	273 0.9×	78	2.3k
T.C. Mathew Kuwait	23	392 0.5×	118 0.3×	98 0.2×	818 2.2×	306 1.0×	54	1.7k
А. О. Шпаков Russia	23	956 1.3×	300 0.7×	37 0.1×	448 1.2×	451 1.5×	365	2.2k
Martijn van Faassen Netherlands	22	621 0.8×	33 0.1×	171 0.4×	371 1.0×	80 0.3×	105	1.9k
Halit Canatan Türkiye	30	794 1.1×	34 0.1×	111 0.3×	351 1.0×	150 0.5×	96	2.9k

Countries citing papers authored by Ashraf Virmani

Since Specialization

Citations

This map shows the geographic impact of Ashraf Virmani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashraf Virmani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashraf Virmani more than expected).

Fields of papers citing papers by Ashraf Virmani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashraf Virmani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashraf Virmani. The network helps show where Ashraf Virmani may publish in the future.

Co-authorship network of co-authors of Ashraf Virmani

This figure shows the co-authorship network connecting the top 25 collaborators of Ashraf Virmani. A scholar is included among the top collaborators of Ashraf Virmani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashraf Virmani. Ashraf Virmani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Veeraiah, Pandichelvam, Rubén Zapata‐Pérez, Esther Phielix, et al.. (2025). Carnitine supplementation improves insulin sensitivity and skeletal muscle acetylcarnitine formation in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 27(5). 2864–2877. 2 indexed citations

Virmani, Ashraf. (2023). Drug abuse results in metabolic and epigenetic changes in body which may contribute to disease risk: Role of L-carnitine and nutrients. PubMed. 3. 10901–10901.

Placidi, Martina, Daria Capece, Paolo Giovanni Artini, et al.. (2023). Acyl-Carnitines Exert Positive Effects on Mitochondrial Activity under Oxidative Stress in Mouse Oocytes: A Potential Mechanism Underlying Carnitine Efficacy on PCOS. Biomedicines. 11(9). 2474–2474. 4 indexed citations

Ulinski, Tim, et al.. (2023). The Role of L-Carnitine in Kidney Disease and Related Metabolic Dysfunctions. SHILAP Revista de lepidopterología. 3(2). 178–191. 10 indexed citations

Placidi, Martina, Giovanna Di Emidio, Ashraf Virmani, et al.. (2022). Carnitines as Mitochondrial Modulators of Oocyte and Embryo Bioenergetics. Antioxidants. 11(4). 745–745. 30 indexed citations

Emidio, Giovanna Di, Martina Placidi, Giulia Rossi, et al.. (2020). Regulatory Functions of L-Carnitine, Acetyl, and Propionyl L-Carnitine in a PCOS Mouse Model: Focus on Antioxidant/Antiglycative Molecular Pathways in the Ovarian Microenvironment. Antioxidants. 9(9). 867–867. 44 indexed citations

Kerner, János, Elizabeth Yohannes, Kwangwon Lee, et al.. (2015). Acetyl-l-carnitine increases mitochondrial protein acetylation in the aged rat heart. Mechanisms of Ageing and Development. 145. 39–50. 23 indexed citations

Virmani, Ashraf, et al.. (2013). Food, Nutrigenomics, and Neurodegeneration—Neuroprotection by What You Eat!. Molecular Neurobiology. 48(2). 353–362. 99 indexed citations

Roscilli, Giuseppe, Emanuele Marra, Federica Mori, et al.. (2013). Carnitines slow down tumor development of colon cancer in the DMH‐chemical carcinogenesis mouse model. Journal of Cellular Biochemistry. 114(7). 1665–1673. 19 indexed citations

10.

Virmani, Ashraf, Angela Koverech, Syed F. Ali, & Zbigniew Binienda. (2011). Acetyl-L-Carnitine Modulates TP53 and IL10 Gene Expression Induced by 3-NPA Evoked Toxicity in PC12 Cells. Current Neuropharmacology. 9(1). 195–199. 11 indexed citations

11.

Virmani, Ashraf, et al.. (2006). Links between Nutrition, Drug Abuse, and the Metabolic Syndrome. Annals of the New York Academy of Sciences. 1074(1). 303–314. 24 indexed citations

12.

Binienda, Zbigniew, et al.. (2006). Co-regulation of dopamine D1 receptor and uncoupling protein-2 expression in 3-nitropropionic acid-induced neurotoxicity: Neuroprotective role of l-carnitine. Neuroscience Letters. 410(1). 62–65. 10 indexed citations

13.

Sadovova, Natalya, Helen M. Duhart, Xiaoting Fu, et al.. (2006). l-Carnitine protects neurons from 1-methyl-4-phenylpyridinium-induced neuronal apoptosis in rat forebrain culture. Neuroscience. 144(1). 46–55. 46 indexed citations

14.

Virmani, Ashraf, et al.. (2004). Role of Mitochondrial Dysfunction in Neurotoxicity of MPP:⁺: Partial Protection of PC12 Cells by Acetyl‐l‐Carnitine. Annals of the New York Academy of Sciences. 1025(1). 267–273. 39 indexed citations

15.

Virmani, Ashraf. (2004). Role of carnitine esters in brain neuropathology. Molecular Aspects of Medicine. 25(5-6). 533–549. 138 indexed citations

16.

Virmani, Ashraf, et al.. (2003). Possible Mechanism for the Neuroprotective Effects of l‐Carnitine on Methamphetamine‐Evoked Neurotoxicity. Annals of the New York Academy of Sciences. 993(1). 197–207. 57 indexed citations

17.

Virmani, Ashraf, et al.. (2002). The Protective Role of l‐Carnitine against Neurotoxicity Evoked by Drug of Abuse, Methamphetamine, Could Be Related to Mitochondrial Dysfunction. Annals of the New York Academy of Sciences. 965(1). 225–232. 60 indexed citations

18.

Virmani, Ashraf. (1996). STRUCTURAL, METABOLIC AND IONIC REQUIREMENTS FOR THE UPTAKE OF1-CARNITINE BY PRIMARY RAT CORTICAL CELLS. Pharmacological Research. 33(1). 19–27. 10 indexed citations

19.

Virmani, Ashraf, Roberto Biselli, Stefania Rossi, et al.. (1995). Protective actions of l-carnitine and acetyl-l-carnitine on the neurotoxicity evoked by mitochondrial uncoupling or inhibitors. Pharmacological Research. 32(6). 383–389. 86 indexed citations

20.

Arduini, Arduino, N. Denisova, Ashraf Virmani, et al.. (1994). Evidence for the Involvement of Carnitine‐Dependent Long‐Chain Acyltransferases in Neuronal Triglyceride and Phospholipid Fatty Acid Turnover. Journal of Neurochemistry. 62(4). 1530–1538. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact